companydata.dkcompanydata.dk

A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR: Financial statements 2018

CVR: 27908047

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR (CVR 27908047) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -12,000 and a net result of DKK -46,000 compared with DKK -43,000 the year before. Equity in the 2018 report amounted to DKK 2,702,000. The solvency ratio was 99.7%.

Gross Profit
DKK -12,000
Profit/Loss
DKK -46,000
Equity
DKK 2,702,000
Total Assets
DKK 2,710,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--12K-46K2.7M-
2017--21K-43K2.7M-
2016--17K-255K2.8M-
2015--28K700K3M-
2014--16K104K2.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Sanne Fredenslund joins the board of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTARJun 7, 2018

As of June 7, 2018, Sanne Fredenslund has joined the board of directors of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR.

Lars Thomas Gunnarsson leaves the board of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTARJun 7, 2018

As of June 7, 2018, Lars Thomas Gunnarsson has left the board of directors of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR.

Sanne Fredenslund joins A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR as directorJun 7, 2018

As of June 7, 2018, Sanne Fredenslund is registered as director of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR.

Lars Thomas Gunnarsson steps down as director of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTARJun 7, 2018

As of June 7, 2018, Lars Thomas Gunnarsson has stepped down as director of A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR.

A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR: The 2017 annual report is outMay 17, 2018

A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR has published its annual report for 2017. Gross profit came to DKK -21,000, and the net result was DKK -43,000.

About A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR

A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR is a Danish company of the type Aktieselskab based in København K, founded in 2004. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Ahmet Turan Kayhan. The board consists of Andrea Panzieri (chair), Allan Funk Nissen and Ahmet Turan Kayhan. The company is owned by BI HOLDING A/S. According to the 2023 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -3,000 compared with DKK 2,000 the year before. Equity in the 2025 report amounted to DKK 2,482,000.

Source: annual report 2025, Danish Business Authority